BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28422420)

  • 1. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
    Shahmarvand N; Oak JS; Cascio MJ; Alcasid M; Goodman E; Medeiros BC; Arber DA; Zehnder JL; Ohgami RS
    Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
    Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
    Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
    Huang YT; Liu XF; Fu RF; Chen YF; Liu W; Xue F; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):480-484. PubMed ID: 30032565
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
    Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation.
    Arana Rosainz MJ; Nguyen N; Wahed A; Lelenwa LC; Aakash N; Schaefer K; Rios A; Kanaan Z; Chen L
    Int J Lab Hematol; 2021 Apr; 43(2):218-226. PubMed ID: 33099879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
    Li S; Gao Y; Li F; Zheng Y; Su Y
    Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2 cases of acute disseminated intravascular coagulation in normal pregnancy and as the first symptom of acute promyelocytic leukemia].
    Kardaszewicz E; Bujak M; Spychałowicz W; Siudyka A; Harbut-Gryłka A
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):257-9. PubMed ID: 2235704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistocytes in disseminated intravascular coagulation.
    Lesesve JF; Martin M; Banasiak C; André-Kerneïs E; Bardet V; Lusina D; Kharbach A; Geneviève F; Lecompte T
    Int J Lab Hematol; 2014 Aug; 36(4):439-43. PubMed ID: 24261329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy evaluation of D-dimer and modified criteria in overt and nonovert disseminated intravascular coagulation diagnosis.
    Li WJ; Sha M; Ma W; Zhang ZP; Wu YJ; Shi DM
    Int J Lab Hematol; 2016 Apr; 38(2):151-9. PubMed ID: 26833979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
    Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofibrinogenemia as a clue in the presumptive diagnosis of acute promyelocytic leukemia.
    Lou Y; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Wei J; Jin J
    Leuk Res; 2016 Nov; 50():11-16. PubMed ID: 27631158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia.
    Mitrovic M; Suvajdzic N; Bogdanovic A; Kurtovic NK; Sretenovic A; Elezovic I; Tomin D
    Med Oncol; 2013 Mar; 30(1):478. PubMed ID: 23371042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Okajima K; Koga S; Okabe H; Inoue M; Takatsuki K
    Acta Haematol; 1989; 81(1):15-8. PubMed ID: 2494830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation.
    Lee HJ; Park HJ; Kim HW; Park SG
    Blood Res; 2013 Dec; 48(4):250-3. PubMed ID: 24466548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.